Stockholders' Equity (Details) - USD ($)	1 Months Ended		9 Months Ended		12 Months Ended
	Apr. 29, 2020	Apr. 29, 2019	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Mar. 29, 2022	Mar. 21, 2022
Stockholders' Equity (Details) [Line Items]
Common stock outstanding							$ 1,750,000
Stock repurchase (in Shares)			317,089
Total unrecognized compensation expense			$ 403,847
Weighted average period			3 years 3 months 10 days
Aggregate intrinsic value of stock options, outstanding			$ 12,980	$ 3,186,961
Aggregate intrinsic value of stock options, exercisable			$ 12,980	2,578,975
Purchase an aggregate of common stock (in Shares)			24,000
Exercise price of common stock (in Dollars per share)			$ 2.66
Stock options, term			10 years
Purchase an aggregate of shares to common stock (in Shares)			224,500
Exercise price (in Dollars per share)			$ 2.66
Aggregate fair value of options granted			$ 636,957	$ 145,522
Repurchased shares of common stock	$ 9,950	$ 500,000
Repurchase plan expires date		Apr. 29, 2020
Treasury shares (in Shares)					22,013
Outstanding common stock						$ 1,750,000
Common stock, treasury shares (in Shares)			349,052		31,963
Treasury Shares [Member]
Stockholders' Equity (Details) [Line Items]
Stock repurchase (in Shares)			317,089
2011 Plan [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares issued under plan (in Shares)			36,402
2016 Plan [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares issued under plan (in Shares)			1,300,000
Percentage of common stock delivered pursuant to incentive stock options			100.00%
Number of stock available for future issuance (in Shares)			773,921